BAJAJ BROKING

Notification close image
No new Notification messages
card image
Crizac IPO is Open!
Apply for the Crizac IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

14993

0

SOTAC

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SOTAC PHARMACEUTICALS LTD performance

Today’s low

Today’s high

₹ 143.10 ₹ 145.00
₹ 143.75

52 week low

52 week high

₹ 88.05 ₹ 202.80
₹ 143.75

Open Price

₹ 145.00

Prev. Close

₹ 143.75

Volume (Shares)

3600.00

Total traded value

₹ 5.17

Upper Circuit

₹ 150.90

Lower Circuit

₹ 136.60

info

SOTAC PHARMACEUTICALS LTD Share Price Update

As of the latest trading session, SOTAC PHARMACEUTICALS LTD share price is currently at ₹ 143.75, which is up by ₹ 0.00 from its previous closing. Today, the stock has fluctuated between ₹ 143.10 and ₹ 145.00. Over the past year, SOTAC PHARMACEUTICALS LTD has achieved a return of 10.29 %. In the last month alone, the return has been 25.00 %. Read More...

Investment Returns

Over 1 Month 25.00% Over 3 Months 26.36% Over 6 Months 35.37% Over 1 Year 10.29%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SOTAC PHARMACEUTICALS LTD fundamentals


  • Market cap (Cr)

    158.80

  • P/E Ratio (TTM)

    33.28

  • Beta

    0.60

  • Book Value / share

    47.99

  • Return on equity

    32.04%

  • EPS (TTM)

    4.32

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.86

info icon alternate text
  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

info icon alternate text

SOTAC PHARMACEUTICALS LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 17.60
Operating Expense 0.00
Net Profit 0.86
Net Profit Margin (%) 4.88
Earnings Per Share (EPS) 0.78
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 13.01
Operating Expense 11.77
Net Profit 1.25
Net Profit Margin (%) 9.60
Earnings Per Share (EPS) 1.13
EBITDA 2.53
Effective Tax Rate (%) 25.14
Particulars MAR 2024 (Values in Cr)
Revenue 16.31
Operating Expense 14.98
Net Profit 1.38
Net Profit Margin (%) 8.46
Earnings Per Share (EPS) 1.25
EBITDA 2.84
Effective Tax Rate (%) 25.80
Particulars DEC 2023 (Values in Cr)
Revenue 17.68
Operating Expense 15.66
Net Profit 1.49
Net Profit Margin (%) 8.42
Earnings Per Share (EPS) 2.65
EBITDA 2.97
Effective Tax Rate (%) 27.66
Particulars SEP 2023 (Values in Cr)
Revenue 14.20
Operating Expense 12.34
Net Profit 1.67
Net Profit Margin (%) 11.76
Earnings Per Share (EPS) 1.52
EBITDA 2.96
Effective Tax Rate (%) 22.32
Particulars MAR 2025 (Values in Cr)
Revenue 62.38
Operating Expense 58.35
Net Profit 4.77
Net Profit Margin (%) 7.64
Earnings Per Share (EPS) 4.32
EBITDA 10.05
Effective Tax Rate (%) 25.58
Particulars MAR 2024 (Values in Cr)
Revenue 67.11
Operating Expense 60.43
Net Profit 5.75
Net Profit Margin (%) 8.56
Earnings Per Share (EPS) 5.24
EBITDA 11.28
Effective Tax Rate (%) 25.90
Particulars MAR 2023 (Values in Cr)
Revenue 57.98
Operating Expense 52.26
Net Profit 4.50
Net Profit Margin (%) 7.76
Earnings Per Share (EPS) 5.58
EBITDA 8.45
Effective Tax Rate (%) 24.66
Particulars MAR 2022 (Values in Cr)
Revenue 73.15
Operating Expense 68.67
Net Profit 3.30
Net Profit Margin (%) 4.51
Earnings Per Share (EPS) 14.33
EBITDA 6.37
Effective Tax Rate (%) 29.63
Particulars MAR 2024 (Values in Cr)
Book Value / Share 40.96
ROE % 11.06
ROCE % 10.19
Total Debt to Total Equity 0.72
EBITDA Margin 8.48
Particulars MAR 2023 (Values in Cr)
Book Value / Share 12.41
ROE % 10.07
ROCE % 12.96
Total Debt to Total Equity 1.13
EBITDA Margin 9.89
Particulars MAR 2021 (Values in Cr)
Book Value / Share 10.84
ROE % -85.41
ROCE % -5.69
Total Debt to Total Equity 5.51
EBITDA Margin 3.21
Particulars MAR 2020 (Values in Cr)
Book Value / Share 13.29
ROE % 2.61
ROCE % 3.90
Total Debt to Total Equity 4.39
EBITDA Margin 7.15
Particulars MAR 2023 (Values in Cr)
Book Value / Share 14.31
ROE % 32.04
ROCE % 29.73
Total Debt to Total Equity 0.64
EBITDA Margin 14.64
Particulars MAR 2022 (Values in Cr)
Book Value / Share 30.87
ROE % 76.91
ROCE % 54.73
Total Debt to Total Equity 1.18
EBITDA Margin 11.25
Particulars MAR 2021 (Values in Cr)
Book Value / Share 20.90
ROE % 34.78
ROCE % 18.64
Total Debt to Total Equity 1.64
EBITDA Margin 7.39
Particulars MAR 2020 (Values in Cr)
Book Value / Share 16.08
ROE % 51.04
ROCE % 15.87
Total Debt to Total Equity 3.33
EBITDA Margin 9.31
Particulars MAR 2019 (Values in Cr)
Book Value / Share 9.63
ROE % 67.86
ROCE % 13.54
Total Debt to Total Equity 8.91
EBITDA Margin 9.78
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 3.41
Total Assets 105.32
Total Liabilities 105.32
Total Equity 49.32
Share Outstanding 11050000
Price to Book Ratio 0.00
Return on Assets (%) 4.06
Return on Capital (%) 5.77
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 9.68
Total Assets 73.63
Total Liabilities 73.63
Total Equity 19.68
Share Outstanding 8050000
Price to Book Ratio 0.00
Return on Assets (%) 3.91
Return on Capital (%) 6.9
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.26
Total Assets 34.69
Total Liabilities 34.69
Total Equity 2.56
Share Outstanding 2300000
Price to Book Ratio 0.00
Return on Assets (%) -6.81
Return on Capital (%) -12.01
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.42
Total Assets 30.38
Total Liabilities 30.38
Total Equity 4.71
Share Outstanding 2300000
Price to Book Ratio 0.00
Return on Assets (%) 0.28
Return on Capital (%) 0.48
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 9.59
Total Assets 54.78
Total Liabilities 54.78
Total Equity 20.99
Share Outstanding 8050000
Price to Book Ratio 0.00
Return on Assets (%) 8.20
Return on Capital (%) 14.2
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 36.29
Total Liabilities 36.29
Total Equity 7.09
Share Outstanding 2300000
Price to Book Ratio 0.00
Return on Assets (%) 9.07
Return on Capital (%) 22.75
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 22.49
Total Liabilities 22.49
Total Equity 4.80
Share Outstanding 2300000
Price to Book Ratio 0.00
Return on Assets (%) 6.59
Return on Capital (%) 12.91
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 21.36
Total Liabilities 21.36
Total Equity 3.69
Share Outstanding 2300000
Price to Book Ratio 0.00
Return on Assets (%) 5.75
Return on Capital (%) 11.24
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.37
Total Assets 16.47
Total Liabilities 16.47
Total Equity 0.91
Share Outstanding 950000
Price to Book Ratio 0.00
Return on Assets (%) 4.59
Return on Capital (%) 8.39
Particulars MAR 2024 (Values in Cr)
Net Income 3.96
Cash from Operations -14.03
Cash from Investing -19.67
Cash from Financing 29.53
Net change in Cash -6.26
Free Cash Flow -1.32
Particulars MAR 2023 (Values in Cr)
Net Income 3.92
Cash from Operations 9.82
Cash from Investing -11.67
Cash from Financing 13.13
Net change in Cash 9.60
Free Cash Flow 18.82
Particulars MAR 2021 (Values in Cr)
Net Income -2.05
Cash from Operations 0.11
Cash from Investing -3.23
Cash from Financing 3.37
Net change in Cash -0.15
Free Cash Flow 3.27
Particulars MAR 2020 (Values in Cr)
Net Income 0.35
Cash from Operations 0.30
Cash from Investing -11.74
Cash from Financing 11.39
Net change in Cash -0.29
Free Cash Flow 10.10
Particulars MAR 2023 (Values in Cr)
Net Income 5.96
Cash from Operations 10.22
Cash from Investing -10.93
Cash from Financing 11.96
Net change in Cash 9.57
Free Cash Flow 17.26
Particulars MAR 2022 (Values in Cr)
Net Income 4.68
Cash from Operations 5.00
Cash from Investing -3.27
Cash from Financing -0.30
Net change in Cash 0.00
Free Cash Flow 8.51
Particulars MAR 2021 (Values in Cr)
Net Income 0.00
Cash from Operations 0.74
Cash from Investing -1.06
Cash from Financing -1.17
Net change in Cash -0.01
Free Cash Flow 1.87
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 35.97 27.46 1.96 275.65 34.11 / 77.70
BLISS GVS PHARMA LTD 155.65 19.46 1.56 1640.09 101.15 / 184.95
CIPLA LTD 1515.95 23.79 3.92 122444.47 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 330.25 12.64 2.67 971.96 163.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 35.97 35.97 5.68 275.65 34.11 / 77.70
AMRUTAJAN HEALTH LTD 724.50 41.21 6.41 2094.58 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8898.25 127.08 28.87 22245.63 6171.25 / 10653.05
BLISS GVS PHARMA LTD 155.65 23.76 1.54 1640.09 101.15 / 184.95

SOTAC PHARMACEUTICALS LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
143.75 0.00 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 140.70
  • 26 Days 126.90
  • 10 Days 134.40
  • 50 Days 123.30
  • 12 Days 132.70
  • 100 Days 123.30
  • 20 Days 128.70
  • 200 Days 125.00
144.98 PIVOT

First Support

144.87

First Resistance

145.22

Second Support

144.63

Second Resistance

145.33

Third Support

144.52

Third Resistance

145.57

RSI

68.39

ADX

14.07

MACD

3.66

Williams % R

0.00

Commodity Channel Index (CCI)

235.81

Date

2025-07-01

Week

19000.00

Same Day

7200.00

Month

10941.00

1 Year

0.59

3 Year

0.89

Over 1 Month

25.00%

down

Over 1 Year

10.29%

down

Over 3 Months

26.36%

down

Over 3 Years

7.49%

down

Over 6 Months

35.37%

down

Over 5 Years

0.00%

down

SOTAC PHARMACEUTICALS LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
12.03%
Promoter Holdings
72.85%
FII
15.11%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Kiran Baldevbhai Jotania 1449000.0 (13.11%) Shareholding of Promoter and Promoter Group
Vishalkumar Devrajbhai Patel 1431500.0 (12.95%) Shareholding of Promoter and Promoter Group
Sharadkumar Dashrathbhai Patel 1431500.0 (12.95%) Shareholding of Promoter and Promoter Group
Dineshkumar Babulal Gelot 1431500.0 (12.95%) Shareholding of Promoter and Promoter Group
Chetankumar Bachubhai Patel 1069250.0 (9.68%) Shareholding of Promoter and Promoter Group
Shaileshkumar Vishnuprasad Patel 805000.0 (7.29%) Shareholding of Promoter and Promoter Group
Nav Capital Vcc - Nav Capital Emerging Star Fund 783600.0 (7.09%) Public Shareholding
Craft Emerging Market Fund Npcc- Elite Capital Fund 705600.0 (6.39%) Public Shareholding
Mitul Shaileshkumar Patel 362250.0 (3.28%) Shareholding of Promoter and Promoter Group
Sambhavnath Investments Andnfinances Private Limit 195600.0 (1.77%) Public Shareholding
Minerva Ventures Fund 181200.0 (1.64%) Public Shareholding
Walpar Nutritions Limited 164400.0 (1.49%) Public Shareholding
Pinki Sharadkumar Patel 17500.0 (0.16%) Shareholding of Promoter and Promoter Group
Sarojben Dineshkumar Gelot 17500.0 (0.16%) Shareholding of Promoter and Promoter Group
Vasantkumar Devrajbhai Patel 17500.0 (0.16%) Shareholding of Promoter and Promoter Group
Dhara Chetankumar Patel 17500.0 (0.16%) Shareholding of Promoter and Promoter Group
Ismani Krupa Cold Storage 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Shiv Shankar Cold Storage 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Satyam Cold Storage 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Chamunda Cement Pipe Industries 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Syzer Lifesciences 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Pinki Sharadkumar Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Saral Pharma 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Shankarlal & Co. 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Ahura Salt Works 0.0 (0.0%) Shareholding of Promoter and Promoter Group
3rd Eye Optics 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Patel Trading Company 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sotac Lifesciences Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sotac Research Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sotac Healthcare Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Tejaben Babulal Mali 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Pravinbhai Trikambhai Jotania 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Nileshbhai Trikambhai Jotania 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Dinaben Chaturbhai Prajapati 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Trikambhai Chaturbhai Prajapati 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Shlok Baldevbhai Jotania 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Hetalben Baldevbhai Panchasara 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Jayeshbhai Baldevdas Prajapati 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Baldevbhai Prabhubhai Panchasara 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Krupali Mahesh Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Patel Ripalben Ratilal 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Patel Pushpaben Ratilal 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Ratilal Meghjibhai Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Prayag Vishalkumar Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Nayanaben Pravinbhai Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Ami Vishalkumar Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Manjulaben Devrajbhai Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Devrajbhai Dhanjibhai Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Hetal Mehulkumar Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Neel Mahendrakumar Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Stuti Chetankumar Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Dhyana Chetankumar Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sarojaben Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sumatiben Deepakkumar Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Ranjanben Shashikant Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Bachubhai Dalabhai Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sumanben Niravkumar Padhiyar 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Vijaykumar Shankarlal Solanki 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Chetnaben Shankarlal Solanki 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Shankarlal Naranji Solanki 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Yashvi Dineshkumar Gelot 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Vedant Dineshkumar Gelot 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Varshaben Kapilkumar Solanki 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Kalpeshkumar Babulal Gelot 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Babulal Ganeshji Gelot 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Nikki Manubhai Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Gitaben Manubhai Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Manubhai Sakalchand Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Krishma Sharadkumar Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Aarav Sharadkumar Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Bhavanaben Manishkumarnpatel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Rekhaben Saileshkumar Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Dipikaben Nileshkumar Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sanjay Dashrathbhai Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Narmadaben Dashrathbhainpatel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Dashrathbhai Ramabhai Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

SOTAC PHARMACEUTICALS LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

SOTAC PHARMACEUTICALS LTD Share Price

Sotac Pharmaceuticals Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name of 'M/s Sotac Pharmaceuticals', pursuant to a Deed of Partnership dated October 28, 2015. Thereafter 'M/s. Sotac Pharmaceuticals' was converted from Partnership Firm to a Private Limited Company in the name of 'Sotac Pharmaceuticals Private Limited' dated December 18, 2015 from the Assistant Registrar of Companies, Gujarat. Later on, Company converted into a Public Limited Company and the name of Company was changed to 'Sotac Pharmaceuticals Limited' dated November 22, 2022 issued by Registrar of Companies, Ahmedabad.

The Company is a part of SOTAC Group, based at Gujarat and is engaged in manufacturing of pharmaceutical products for different marketers on loan license or contract manufacturing basis. The Company is pharma manufacturer, specializing in manufacturing of a wide range of pharmaceutical products such as Non Beta-Lactam (general) tablets, beta-lactam coated tablets, beta-lactam uncoated tablets, Non Beta-Lactam (general) capsules, beta-lactam capsules, oral liquid, dry syrup and external preparations such as nasal spray, relief spray and cream.

The Company's therapeutic portfolio include Anti-Diabetic, Anti-Psychotic, Vitamins, Minerals, Iron, Anti-Cold, AntiAllergic, Derma Products, Antacid, Anti-Ulcerants, PPI, Anti-Emetics, Cardiac, Anti-Hypertensives, Analgesic, AntiPyretic, Anti-Inflammatory, Anti-Bacterial, Anti-Viral, General Antibiotics IP-Lactams & Non-IP-Lactams, Anti-Fungal, Cephalosporin. Consequently, as a Group, it cater to a wide spectrum of companies for formulation development, clinical batch production, commercial scale productions.

The Company commenced manufacturing facility in year 2017, which had an installed capacity to manufacture 90 Crore tables / year, 14 Crore Capsules / year. Later, in 2022, the Company acquired 71% holding in SOTAC Healthcare Private Limited and 100% holding in SOTAC Research Private Limited, thus making them as wholly owned Subsidiary Companies in April, 2022. Thereafter, it started a new venture, SOTAC Lifescience Private Limited and held 51% of total paid-up capital in it.

In April 2023, Company made an IPO of 3000000 fresh issue of Equity Shares of face value of Rs 10 each by raising funds aggregating to Rs 33 Crore.

Parent organization Indian Private
NSE symbol SOTAC
Founded 2015
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Sotac Pharmaceuticals Ltd?

Answer Field

Sotac Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 02 2025 12:00 AM.

What is the Market Cap of Sotac Pharmaceuticals Ltd Share?

Answer Field

The market cap of Sotac Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 02 2025 12:00 AM.

What is the 52 Week High and Low of Sotac Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Sotac Pharmaceuticals Ltd for NSE is ₹ 202.80 and ₹ 88.05 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Sotac Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 8.90%.

What is the P/E Ratio of Sotac Pharmaceuticals Ltd Share?

Answer Field

As on Jul 02 2025 12:00 AM the price-to-earnings (PE) ratio for Sotac Pharmaceuticals Ltd share is 33.28.

What is the PB ratio of Sotac Pharmaceuticals Ltd Share?

Answer Field

As on Jul 02 2025 12:00 AM, the price-to-book (PB) ratio for Sotac Pharmaceuticals Ltd share is 47.99.

How to Buy Sotac Pharmaceuticals Ltd Share?

Answer Field

You can trade in Sotac Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Sotac Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Sotac Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sotac Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|